ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Drug-specific differences in fatal adverse events among PARP inhibitors: a FAERS pharmacovigilance study.

Duo Meng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.